BPH Global Ltd (BP8.XA)

0.0030 0.0000 (0.00%) At close: 02:29PM AEST

BPH Global Ltd

Block Arcade, 96 Elizabeth St.
Level 3 Office 324
Melbourne, VIC 3000
Australia
61 2 8072 1400
https://www.scu.com.sg

Sector(s): 
Industry: 
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Matthew Robert Leonard	MD & Executive Director	115.42k	N/A	N/A
Mr. Chow-Yee Koh	Chief Financial Officer	222.43k	N/A	1976
Mr. Francesco Cannavo	Part-Time Executive Director	188.59k	N/A	N/A
Mr. Justyn Peter Stedwell B.Com, B.Com.	Company Secretary	N/A	N/A	1981

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.

Corporate governance

BPH Global Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.